Government allows Korean pharmaceutical companies to manufacture foreign new drugs and orphan drugs under contract
New drugs and orphan drugs whose technology transferred to a Korean manufacturer if sold in other countries will now be available to manufacturer under contract even in Korea.
As the Pharmaceutical Affairs Law is revised(24 October 2017) which extends the range of contract manufacturing business...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
